UK markets closed

GSK Jan 2024 40.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.0500+0.1000 (+10.53%)
At close: 12:55PM EDT
Full screen
Previous close0.9500
Open1.0300
Bid1.0000
Ask1.2500
Strike40.00
Expiry date2024-01-19
Day's range1.0300 - 1.0500
Contract rangeN/A
Volume105
Open interest1k
  • Sky News

    GSK poaches Burberry CFO to create all-female top team

    GSK, the FTSE-100 pharmaceuticals giant, has poached Burberry Group's finance chief to create a rare all-female executive leadership team in London's blue-chip share index. Sky News has learnt that GSK could announce as soon as Monday morning that it has recruited Julie Brown to replace Iain Mackay, who has served as its chief financial officer since 2019. The appointment of Ms Brown comes during a period of seismic change for GSK, which demerged its consumer healthcare business - now called Haleon - in a £30bn deal in July.

  • Zacks

    Spero (SPRO) Skyrockets 168% on Licensing Deal With GSK

    The exclusive licensing agreement with GSK will fund Spero's (SPRO) existing operations and extend its current cash runway beyond 2024.

  • Zacks

    Pharma Stock Roundup: EU Nod to AZN & RHHBY Drugs, FDA Updates for LLY & MRK

    Roche's (RHHBY) eye drug, Vabysmo and AstraZeneca's (AZN) asthma drug Tezspire get approval in Europe. The FDA approves expanded use of Lilly's (LLY) cancer drug, Retevmo.